van Houte Hans Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$5.98M

Insider Activity of van Houte Hans

According to the SEC Form 4 filings, van Houte Hans, being in a position of

  1. Chief Financial Officer at Nurix Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30544 shares for $590,823,
    over all time since 2021-02-18, has bought 0 shares, and sold 261455 shares for $6.8M.

Biography of van Houte Hans

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $590,8236100

Comparison of Insiders on Amount of Buys and Sells

2026-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,834
0.0025%
$26.28$74,475-3.88%
2026-08-04SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
4,761
0.0045%
$24.36$115,989+3.44%
2026-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,845
0.0027%
$23.38$66,524+8.23%
2026-05-05SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
14,055
0.0159%
$16.60$233,319+42.61%
2026-04-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,388
0.0028%
$16.65$39,749+41.74%
2026-01-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
3,661
0.0042%
$16.60$60,767+7.51%
2025-11-03SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
6,284
0.0079%
$12.56$78,931+43.34%
2025-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
3,130
0.005%
$12.80$40,054+41%
2025-08-01SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
5,402
0.0069%
$11.03$59,598+45.02%
2025-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
4,304
0.0057%
$12.01$51,695+34.43%
2025-05-02SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
6,198
0.0082%
$11.33$70,243+12.02%
2025-04-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,438
0.0032%
$11.50$28,041+8.76%
2025-03-03SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
5,825
0.008%
$14.49$84,388-15.72%
2025-01-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,811
0.004%
$19.85$55,809-40.26%
2024-11-01SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
3,546
0.005%
$24.28$86,083-51.25%
2024-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,368
0.0034%
$24.30$57,554-50.37%
2024-08-26SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
20,000
0.0305%
$25.22$504,370-37.87%
2024-08-01SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
3,477
0.0054%
$21.45$74,576-12.16%
2024-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
2,490
0.0038%
$20.67$51,463-8.88%
2024-06-20SaleNurix Therapeutics, Inc.
NRIX
Chief Financial Officer
20,000
0.0418%
$20.01$400,216-4.55%
Total: 36
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.